Skip to main content
. 2024 Mar 14;29(6):527–533. doi: 10.1093/oncolo/oyae035

Table 1.

Patient selection by cancer type, total, and by cancer type.

Number remaining (% of starting)
Total Colorectal Head and neck Lung
Newly diagnosed stage IV colorectal (2004-2011), stages II-IV head and neck (2006-2011), or stage IV lung adenocarcinoma (2006-2011), age 18-64, with insurance coverage at time of diagnosis 3840 (100) 954 (100) 1345 (100) 1541 (100)
Received any component of a high- or low-cost treatment regimen within 120 days of diagnosis 1556 (40.5) 508 (53.2) 526 (39.1) 522 (33.9)
Received all components of a high- or low-cost treatment regimen within 60 days of starting treatment 1531 (39.9) 501 (52.5) 525 (39.0) 505 (32.8)
Continuous insurance enrollment for 180 days before and 60 days after starting treatment 812 (21.1) 263 (27.6) 311 (23.1) 238 (15.4)